Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-13

Clinical Trial Update: mRNA Expression and Genetic Polymorphisms Affecting DRD3 (rs6280) and HTR2A (rs6313) in Bruxism

View source ↗

Summary

A planned clinical study from the University of Monastir is investigating whether mRNA expression and DRD3 rs6280 and HTR2A rs6313 polymorphisms are associated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Monastir | Conditions: Bruxism | Status: NOT_YET_RECRUITING